Forbes contributors publish independent expert analyses and insights. Jesse Pines is an expert in healthcare innovation and wellness. This voice experience is generated by AI. Learn more. This voice ...

ORLANDO, Fla. — The patient in Room 373 refuses to leave. Subscribe to read this story ad-free Get unlimited access to ad-free articles and exclusive content. Tallahassee Memorial Healthcare earlier ...

At age 66, Richard "Dick" Nash first suspected something might be wrong when he participated in a Dallas walk for juvenile diabetes in honor of his granddaughter. "It was only two miles – no big deal ...

Patients are now expected to navigate much of their care online — from seeing their doctor on a screen to booking appointments, refilling prescriptions, and checking test results through health care ...

A Houston doctor has been indicted on charges of falsifying medical records for five patients, making them ineligible to receive a liver transplant, federal prosecutors announced on Thursday. Dr. John ...

Dr. Lamas, a contributing Opinion writer, is a pulmonary and critical care physician at Brigham and Women’s Hospital in Boston. See more of our coverage in your search results.Encuentra más de nuestra ...

The impact of GLP-1 medications on weight loss is undeniable, but emerging research suggests the results may only be temporary. A growing body of evidence shows that when patients stop taking GLP-1 ...

Abstract: Parkinson's disease is a chronic, progressive neurodegenerative disorder caused by the gradual damage of dopamine-producing neurons in the substantia nigra. It poses certain burdens on ...

In nonpsychiatric settings, primary care physicians consider 17% of their patients as “difficult,” particularly those who have anxiety or depression, according to research published Jan. 12 in Annals ...

On demand, not on hold — new research revealed the top hurdles that send patients running to a new doctor. According to a survey of 2,000 Americans who’ve been to the doctor within the last year, ...

The proprotein convertase subtilisin–kexin type 9 (PCSK9) inhibitor evolocumab reduces the risk of major adverse cardiovascular events (MACE) among patients with a previous myocardial infarction, ...